/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Pacira Pharmaceuticals, Inc. Share Price Today: Live Updates & Key Insights

Pacira Pharmaceuticals, Inc. share price today is $22.1, up -2.04%. The stock opened at $22.38 against the previous close of $22.57, with an intraday high of $22.38 and low of $21.865.

Pacira Pharmaceuticals, Inc. Share Price Chart

style
pb-0

Pacira Pharmaceuticals, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Pacira Pharmaceuticals, Inc. Share Price Performance

$22.1 -0.0204(-2.04%) PCRX at 23 Mar 2026 02:41 PM Drug Manufacturers - Specialty & Generic
Lowest Today 21.865
Highest Today 22.38
Today’s Open 22.38
Prev. Close 22.57
52 Week High 27.64
52 Week Low 18.80
Day’s Range: Low 21.865 High 22.38
52-Week Range: Low 18.80 High 27.64
1 day return -
1 Week return -2.27
1 month return -4.21
3 month return -14.93
6 month return -16.25
1 year return -10.92
3 year return -43.74
5 year return -68.46
10 year return -

Pacira Pharmaceuticals, Inc. Institutional Holdings

BlackRock Inc 18.12

Vanguard Group Inc 11.89

Doma Perpetual Capital Management LLC 6.86

iShares Core S&P Small-Cap ETF 6.47

D. E. Shaw & Co LP 5.04

Dimensional Fund Advisors, Inc. 4.82

State Street Corp 4.69

Renaissance Technologies Corp 4.65

American Century Companies Inc 3.30

The Goldman Sachs Group Inc 3.24

Vanguard Total Stock Mkt Idx Inv 3.17

Geode Capital Management, LLC 2.89

Morgan Stanley - Brokerage Accounts 2.82

iShares Russell 2000 ETF 2.69

Balyasny Asset Management LLC 2.34

Vanguard Small Cap Index 2.29

JPMorgan Chase & Co 2.15

UBS Group AG 2.11

Citadel Advisors Llc 2.02

Impax Asset Management Group PLC 1.85

Impax Small Cap Institutional 1.85

Impax US Small Cap Strategy Composite 1.85

Charles Schwab Investment Management Inc 1.67

Avantis US Small Cap Value ETF 1.55

Vanguard Small Cap Value Index Inv 1.47

Northern Trust Corp 1.42

DFA US Small Cap Value I 1.33

Wellington Management Company LLP 1.28

Amvescap Plc. 1.28

Vanguard Institutional Extnd Mkt Idx Tr 1.16

Fidelity Small Cap Index 1.08

State Street SPDR Port S&P 600 Sm CpETF 0.98

iShares S&P Small-Cap 600 Growth ETF 0.91

iShares Russell 2000 Value ETF 0.87

DWS Small Cap Core S 0.86

Small Cap Core Equity Composite 0.86

State St Russell Sm/Mid Cp® Indx SL Cl I 0.68

Applied Finance Explorer Institutional 0.67

Vanguard Tax-Managed Small Cap Adm 0.63

State Street® SPDR® S&P® PhrmctlsETF 0.60

Pacira Pharmaceuticals, Inc. Market Status

Strong Buy: 1

Buy: 1

Hold: 3

Sell: 1

Strong Sell: 0

Pacira Pharmaceuticals, Inc. Fundamentals

Market Cap 951.20 M

PB Ratio 1.3185

PE Ratio 138.1875

Enterprise Value 1093.64 M

Total Assets 1264.92 M

Volume 2128297

Pacira Pharmaceuticals, Inc. Company Financials

Annual Revenue FY25:726411000 726.4M, FY23:665689000 665.7M, FY22:666823000 666.8M, FY21:541533000 541.5M, FY20:420830000 420.8M

Annual Profit FY25:null 0.0M, FY23:466796000 466.8M, FY22:467528000 467.5M, FY21:401278000 401.3M, FY20:303502000 303.5M

Annual Net worth FY25:26714000 26.7M, FY23:6983000 7.0M, FY22:15909000 15.9M, FY21:41980000 42.0M, FY20:145523000 145.5M

Quarterly Revenue Q4/2025:196873000 196.9M, Q3/2025:179516000 179.5M, Q2/2025:181099000 181.1M, Q1/2025:168923000 168.9M, Q3/2024:168573000 168.6M

Quarterly Profit Q4/2025:null 0.0M, Q3/2025:145238000 145.2M, Q2/2025:140233000 140.2M, Q1/2025:134617000 134.6M, Q3/2024:129709000 129.7M

Quarterly Net worth Q4/2025:21317000 21.3M, Q3/2025:5432000 5.4M, Q2/2025:-4847000 -4.8M, Q1/2025:4812000 4.8M, Q3/2024:-143466000 -143.5M

About Pacira Pharmaceuticals, Inc. & investment objective

Company Information Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Organisation Drug Manufacturers - Specialty & Generic

Employees 825

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Frank D. Lee

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Pacira Pharmaceuticals, Inc. FAQs

What is the share price of Pacira Pharmaceuticals, Inc. today?

The current share price of Pacira Pharmaceuticals, Inc. is $22.1.

Can I buy Pacira Pharmaceuticals, Inc. shares in India?

Yes, Indian investors can buy Pacira Pharmaceuticals, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Pacira Pharmaceuticals, Inc. shares in India?

You can easily invest in Pacira Pharmaceuticals, Inc. shares from India by:

Can I buy fractional shares of Pacira Pharmaceuticals, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Pacira Pharmaceuticals, Inc.?

Pacira Pharmaceuticals, Inc. has a market cap of $951.20 M.

In which sector does Pacira Pharmaceuticals, Inc. belong?

Pacira Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Pacira Pharmaceuticals, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Pacira Pharmaceuticals, Inc.?

The PE ratio of Pacira Pharmaceuticals, Inc. is 138.19 and the PB ratio is 1.32.